Table 3.
Adjusted ORs (95% CIs) for Medication Use and Risk Factor Control Among US Adults With ASCVD, Weighted
| Socioeconomic subgroups | Use of statin (n=2897)* | Use of antihypertensive agents among those with self‐reported hypertension (n=3642)* | Use of antidiabetic in those with self‐reported diabetes (n=1435)* | All controlled (BP <140/90 mm Hg, non–HDL‐C <100 mg/dL, HbA1c <7%) (n=627)* | Non–HDL‐C <100 mg/dL (n=1076)* | BP <140/90 mm Hg (n=3269)* | HbA1c <7% (n=4189)* |
|---|---|---|---|---|---|---|---|
| Sex | |||||||
| Female adults | Reference | Reference | Reference | Reference | Reference | Reference | Reference |
| Male adults | 1.74 (1.47–2.70) | 1.01 (0.73–1.40) | 1.47 (0.94–2.28) | 1.68 (1.30–2.16) | 1.47 (1.19–1.8) | 1.56 (1.33–1.82) | 0.65 (0.52–0.83) |
| Race and ethnicity† | |||||||
| Non‐Hispanic White population | Reference | Reference | Reference | Reference | Reference | Reference | Reference |
| Hispanic population | 0.84 (0.66–1.05) | 0.59 (0.41–0.86) | 0.97 (0.60–1.56) | 0.88 (0.62–1.24) | 1.11 (0.85–1.46) | 0.89 (0.69–1.15) | 0.53 (0.40–0.70) |
| Non‐Hispanic Black population | 0.75 (0.61–0.93) | 0.87 (0.63–1.21) | 1.05 (0.68–1.62) | 1.03 (0.76–1.38) | 1.56 (1.25–1.94) | 0.51 (0.41–0.62) | 0.60 (0.47–0.75) |
| Other population | 1.59 (1.15–2.22) | 1.65 (0.85–3.20) | 0.84 (0.38–1.88) | 0.94 (0.57–1.54) | 1.24 (0.85–1.82) | 1.09 (0.79–1.52) | 0.59 (0.38–0.93) |
| Education | |||||||
| Less than high school | Reference | Reference | Reference | Reference | Reference | Reference | Reference |
| High school | 1.33 (1.90–1.62) | 1.37 (0.90–2.07) | 1.01 (0.61–1.69) | 1.25 (0.92–1.71) | 1.43 (1.14–1.80) | 0.94 (0.76–1.18) | 1.28 (0.96–1.72) |
| More than high school | 1.50 (0.86–1.29) | 0.80 (0.56–1.14) | 0.61 (0.37–1.00) | 1.68 (1.31–2.16) | 1.55 (1.26–1.92) | 1.03 (0.85–1.25) | 2.01 (1.54–2.65) |
| Insurance | |||||||
| No | Reference | Reference | Reference | Reference | Reference | Reference | Reference |
| Yes | 2.34 (1.61–3.39) | 3.13 (2.15–4.56) | 1.00 (0.51–1.97) | 1.42 (0.81–2.51) | 1.42 (0.87– 2.30) | 1.27 (0.92–1.74) | 1.01 (0.66–1.56) |
| Age groups, y | |||||||
| 20–44 | Reference | Reference | Reference | Reference | Reference | Reference | Reference |
| 45–64 | 4.35 (3.30–6.23) | 3.39 (2.12–5.43) | 3.73 (1.75–7.96) | 0.59 (0.37–0.93) | 0.79 (0.52–1.22) | 0.50 (0.34–0.73) | 0.42 (0.23–0.74) |
| ≥65 | 6.21 (4.27–9.40) | 7.14 (4.50–11.36) | 4.20 (1.99–8.87) | 1.00 (0.65–1.55) | 1.7 (1.15–2.53) | 0.25 (0.17–0.38) | 0.39 (0.22–0.69) |
| Poverty/income ratio‡ | |||||||
| <1.3 | Reference | Reference | Reference | Reference | Reference | Reference | Reference |
| 1.3 to <3 | 1.24 (1.40–1.48) | 1.28 (0.91–1.79) | 0.84 (0.55–1.28) | 1.12 (0.86–1.46) | 1.13 (0.91–1.39) | 1.11 (0.93–1.33) | 0.89 (0.70–1.14) |
| ≥3 | 1.83 (1.52–2.19) | 1.52 (0.98–2.36) | 1.25 (0.73–2.14) | 1.35 (1.2–1.79) | 1.33 (1.4–1.7) | 1.35 (1.10–1.66) | 0.94 (0.68–1.30) |
| BMI categories, kg/m2 | |||||||
| <18.5 | 0.59 (0.22–1.62) | 1.11 (0.32–3.78) | 1.28 (0.24–6.92) | 2.15 (0.77–6.40) | 1.95 (0.81–4.67) | 0.99 (0.50–1.97) | 1.73 (0.51–5.84) |
| 18.5 to <25 | Reference | Reference | Reference | Reference | Reference | Reference | Reference |
| 25 to <30 | 1.34 (1.50–1.72) | 1.08 (0.70–1.67) | 0.94 (0.55–1.62) | 0.88 (0.64–1.21) | 0.71 (0.54–0.93) | 1.11 (0.88–1.40) | 0.73 (0.50–1.07) |
| ≥30 | 1.48 (1.17–1.88) | 1.76 (1.11–2.77) | 1.48 (0.85–2.58) | 0.65 (0.45–0.95) | 0.65 (0.49–0.86) | 1.14 (0.92–1.40) | 0.22 (0.15–0.33) |
ASCVD indicates atherosclerotic cardiovascular disease; BMI, body mass index; BP, blood pressure; HbA1c, hemoglobin A1c; non–HDL‐C, non–high‐density lipoprotein cholesterol (calculated as total cholesterol minus HDL‐C); and OR, odds ratio.
ORs with 95% CIs were adjusted for age, sex, racial and ethnic group, educational level, family income, insurance, and weight status.
Race and ethnicity was determined by self‐report in fixed categories. Other race included Asian American, American Indian or Alaskan Native, Native Hawaiian or Pacific Islander, multiple races or ethnicities, or unknown.
Ratio of family income/federal poverty threshold in a particular year. A higher poverty/income ratio corresponds to a higher level of family income.